syringaldehyde has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MF; Cheng, JT; Chung, HH; Huang, CH | 1 |
| Chen, TH; Fu, YS; Huang, L; Lai, D; Weng, CF; Weng, L; Weng, WH; Zheng, Q | 1 |
| Cheng, JT; Chung, HH; Huang, CH; Kuo, SC | 1 |
3 other study(ies) available for syringaldehyde and Alloxan Diabetes
| Article | Year |
|---|---|
Antihyperglycemic effect of syringaldehyde in streptozotocin-induced diabetic rats.
Topics: Animals; Benzaldehydes; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hibiscus; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Molecular Structure; Plant Stems; Rats | 2012 |
Syringaldehyde promoting intestinal motility with suppressing α-amylase hinders starch digestion in diabetic mice.
Topics: alpha-Amylases; Animals; Benzaldehydes; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Gastrointestinal Motility; Glucose Tolerance Test; Jejunum; Male; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Muscarinic Agonists; Receptors, Muscarinic; Starch | 2021 |
Decrease of hyperglycemia by syringaldehyde in diabetic rats.
Topics: Animals; Benzaldehydes; Blood Glucose; Diabetes Mellitus, Experimental; Fructose; Glucose Clamp Technique; Glucose Transporter Type 4; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Liver; Male; Muscle, Skeletal; Phosphoenolpyruvate Carboxykinase (GTP); Postprandial Period; Rats; Rats, Wistar | 2014 |